Bayesian Capital Management, LP Ocugen, Inc. Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.4 - $0.62 $19,080 - $29,574
47,700 New
47,700 $19,000
Q4 2022

Feb 14, 2023
BUY
$1.11 - $1.87 $11,703 - $19,717
10,544 Added 45.84%
33,544 $43,000
Q3 2022

Nov 14, 2022
BUY
$1.75 - $3.1 $40,250 - $71,300
23,000 New
23,000 $41,000

Others Institutions Holding OCGN

# of Institutions
124
Shares Held
78.3M
Call Options Held
535K
Put Options Held
523K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $167M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email